PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.690
+0.130 (8.33%)
At close: Jun 6, 2025, 4:00 PM
1.680
-0.010 (-0.59%)
After-hours: Jun 6, 2025, 7:55 PM EDT
PDS Biotechnology Employees
PDS Biotechnology had 24 employees as of December 31, 2024. The number of employees decreased by 1 or -4.00% compared to the previous year.
Employees
24
Change (1Y)
-1
Growth (1Y)
-4.00%
Revenue / Employee
n/a
Profits / Employee
-$1,478,995
Market Cap
77.25M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
PDSB News
- 5 days ago - PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune® HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 16 days ago - PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 18 days ago - PDS Biotech to Participate at the A.G.P. Virtual Annual Healthcare Company Showcase - GlobeNewsWire
- 24 days ago - PDS Biotechnology Corporation (PDSB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update - GlobeNewsWire
- 4 weeks ago - PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting - GlobeNewsWire
- 4 weeks ago - PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results - GlobeNewsWire